| 1. |
Gan Q, Zhu Y, Guo Y, et al. T cell heterogeneity in asthma pathogenesis: from immunological mechanisms to biological targeted therapies[J]. Front Immunol. 2025, 16: 1658774.
|
| 2. |
Sowerby J, Choi J, Rao DA. T Peripheral Helper Cells in Lymphoid Aggregate and Tertiary Lymphoid Structure Formation[J]. Immunol Rev, 2026, 337(1): e70088.
|
| 3. |
中華醫學會呼吸病學分會哮喘學組. 支氣管哮喘防治指南(2020年版)[J]. 中華結核和呼吸雜志, 2020, 43(12): 1023-1048.
|
| 4. |
ulcerative colitis Group, Chinese Society of Gastroenterology, Chinese Medical Association. Chinese consensus on diagnosis and treatment in inflammatory bowel disease(2018, Beijing)[J]. J Dig Dis. 2021, 22(6): 298-317.
|
| 5. |
Bick F, Brenis Gómez CM, Lammens I, et al. IL-2 family cytokines IL-9 and IL-21 differentially regulate innate and adaptive type 2 immunity in asthma[J]. J Allergy Clin Immunol, 2024, 154(5): 1129-1145.
|
| 6. |
Kudo T, Shimizu T. Mucosal immune systems of pediatric inflammatory bowel disease: A review[J]. Pediatr Int, 2023, 65(1): e15511.
|
| 7. |
Olatunde AC, Hale JS, Lamb TJ. Cytokine-skewed Tfh cells: functional consequences for B cell help[J]. Trends Immunol, 2021, 42(6): 536-550. DOI: 10. 1016/j. it. 2021. 04. 006.
|
| 8. |
Yao Y, Chen CL, Yu D, et al. Roles of follicular helper and regulatory T cells in allergic diseases and allergen immunotherapy[J]. Allergy, 2021, 76(2): 456-470.
|
| 9. |
Zhu Y, Jiang Q, Lei C, et al. The response of CD27+CD38+ plasmablasts, CD24hiCD38hi transitional B cells, CXCR5-ICOS+PD-1+ Tph, Tph2 and Tfh2 subtypes to allergens in children with allergic asthma[J]. BMC Pediatr, 2024, 24(1): 154.
|
| 10. |
Zhu C, Ni X, Xu J, et al. Interaction Between Tfh/Tfr Ratio and Regulatory B Cell in Autoimmune Diseases[J]. Iran J Immunol, 2025, 22(1): 1-12.
|
| 11. |
Zhu X, Chen X, Cao Y, et al. Optimal CXCR5 expression during Tfh maturation involves the Bhlhe40-Pou2af1 axis[J]. Cell Rep, 2025, 44(11): 116470.
|
| 12. |
Liu B, Qi H. In Vivo Migration and Tfh Cell Interactions[J]. Methods Mol Biol, 2022, 2380: 99-109.
|
| 13. |
李東升, 李風森, 常文俊. 哮喘急性發作期患者外周血Bcl-6mRNA、Blimp-1mRNA、IL-21水平變化及意義[J]. 臨床肺科雜志, 2018, 23(01): 70-72+78.
|
| 14. |
Wang J, Wu Z, Huang Y, et al. IRF4 induces M1 macrophage polarization and aggravates ulcerative colitis progression by the Bcl6-dependent STAT3 pathway[J]. Environ Toxicol, 2024, 39(4): 2390-2404.
|
| 15. |
Olbrich P, Freeman AF. STAT1 and STAT3 gain of function: clinically heterogenous immune regulatory disorders[J]. Curr Opin Allergy Clin Immunol, 2024, 24(6): 440-447.
|
| 16. |
Damasceno LEA, Prado DS, Veras FP, et al. PKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning STAT3 activation[J]. J Exp Med, 2020, 217(10): e20190613.
|
| 17. |
郭純鈺, 應培挺, 郭莉. STAT3基因突變相關免疫性疾病的研究進展[J]. 中國新藥與臨床雜志, 2024, 43(2): 81-87.
|
| 18. |
Kim S, Boehme L, Nel L, et al. Defective STAT5 Activation and Aberrant Expression of BCL6 in Naive CD4 T Cells Enhances Follicular Th Cell-like Differentiation in Patients with Granulomatosis with Polyangiitis[J]. J Immunol, 2022, 208(4): 807-818.
|
| 19. |
Cheng Q, Yang X, Zou T, et al. RACK1 enhances STAT3 stability and promotes T follicular helper cell development and function during blood-stage Plasmodium infection in mice[J]. PLoS Pathog, 2024, 20(7): e1012352.
|